| Serial Number | 88573422 |
| Word Mark | NINEMETERS BIOPHARMA |
| Filing Date | Friday, August 9, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, March 27, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 24, 2019 |
| Goods and Services | Pharmaceutical and biological preparations for the treatment of anorectal diseases and gastrointestinal and liver disorders; Targeted pharmacological and biological treatments for anorectal diseases, liver, and gastrointestinal disorders such as fecal incontinence, pruritus ani, and radiation proctitis; Prescription and non-prescription pharmacological and biological treatments administered in various pharmaceutical technological forms namely, in solid form pills, tablets, capsules, caplets, sachets, in semi-liquid form namely, gels, ointments and pastes, suppositories, in liquid form namely, drops, injectables, infusions, in gaseous form namely, inhalants, or in sprays, namely, intranasally administered medications, for the treatment of anorectal diseases and gastrointestinal illnesses and disorders; Capsules sold empty for pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Suppositories with proprietary delivery system for the precise delivery of drugs that target conditions and diseases of the anorectal region; Suppositories |
| Pseudo Mark | NINE METERS BIO PHARMA |
| Disclaimer with Predetermined Text | "BIOPHARMA" |
| Goods and Services | Pharmaceutical research and development services; Medical and scientific research information in the field of novel pharmaceutical discovery and development; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of novel pharmaceutical treatments and clinical trials; Providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials; Clinical trials services for others |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 26, 2019 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 26, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | 9 METERS BIOPHARMA |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 03 - Corporation |
| Address | RALEIGH, NC 27615 |
| Party Name | RDD Pharma, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10019 |
| Party Name | RDD Pharma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10019 |
| Event Date | Event Description |
| Monday, March 27, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 27, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Saturday, August 13, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, August 12, 2022 | SOU EXTENSION 5 GRANTED |
| Thursday, August 4, 2022 | SOU EXTENSION 5 FILED |
| Friday, August 12, 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Thursday, August 4, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, February 15, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, February 11, 2022 | SOU EXTENSION 4 GRANTED |
| Friday, February 11, 2022 | SOU EXTENSION 4 FILED |
| Friday, February 11, 2022 | TEAS EXTENSION RECEIVED |
| Wednesday, December 22, 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Friday, August 20, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, August 18, 2021 | SOU EXTENSION 3 GRANTED |
| Wednesday, August 18, 2021 | SOU EXTENSION 3 FILED |
| Wednesday, August 18, 2021 | TEAS EXTENSION RECEIVED |
| Saturday, December 12, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 10, 2020 | SOU EXTENSION 2 GRANTED |
| Thursday, December 10, 2020 | SOU EXTENSION 2 FILED |
| Thursday, December 10, 2020 | TEAS EXTENSION RECEIVED |
| Saturday, August 15, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, August 13, 2020 | SOU EXTENSION 1 GRANTED |
| Thursday, August 13, 2020 | SOU EXTENSION 1 FILED |
| Thursday, August 13, 2020 | TEAS EXTENSION RECEIVED |
| Tuesday, February 18, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 24, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, December 24, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, December 4, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, November 18, 2019 | ASSIGNED TO LIE |
| Thursday, November 14, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, November 14, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, November 14, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 14, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, November 14, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, November 14, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 14, 2019 | NON-FINAL ACTION E-MAILED |
| Thursday, November 14, 2019 | NON-FINAL ACTION WRITTEN |
| Thursday, November 7, 2019 | ASSIGNED TO EXAMINER |
| Monday, August 26, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, August 13, 2019 | NEW APPLICATION ENTERED |